| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/06/1999 | EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity |
| 10/06/1999 | EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 10/06/1999 | EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 10/06/1999 | EP0946495A1 Phenyl acetamides as spla2 inhibitors |
| 10/06/1999 | EP0946196A1 Method for treating symptoms of diabetes |
| 10/06/1999 | EP0946189A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 10/06/1999 | EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy |
| 10/06/1999 | CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 10/06/1999 | CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes |
| 10/06/1999 | CN1230892A Use of proteins as agents against autoimmune diseases |
| 10/06/1999 | CN1230891A Lectin compositions and uses thereof |
| 10/06/1999 | CN1230407A Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 10/05/1999 | US5962707 19-nor-vitamin D3 compounds with calcemic activity |
| 10/05/1999 | US5962509 Dithiolylidene acetamide derivatives |
| 10/05/1999 | US5962497 A 3,4-diphenyl substituted chroman compound |
| 10/05/1999 | US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors |
| 10/05/1999 | US5962479 Psychological and nervous sytem disorders |
| 10/05/1999 | US5962475 Osteoporosis, restenosis, breast cancer |
| 10/05/1999 | US5962470 Heterocyclic compounds having anti-diabetic activity and their use |
| 10/05/1999 | US5962455 Eating disorders, cardiovascular disorders, hypotensive agents |
| 10/05/1999 | US5962411 Human growth hormone variants and methods of administering same |
| 10/05/1999 | US5962049 Boron carbohydrate complexes and uses thereof |
| 10/05/1999 | US5961981 Biologically-active compositions extracted from dictyotales plant family |
| 09/30/1999 | WO1999049027A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | WO1999048888A1 Imidazolone anorectic agents: ii. phenyl derivatives |
| 09/30/1999 | WO1999048887A1 Imidazolone anorectic agents: iii. heteroaryl derivatives |
| 09/30/1999 | WO1999048873A1 Imidazolone anorectic agents: i. acyclic derivatives |
| 09/30/1999 | WO1999048488A2 Methods for decreasing beta amyloid protein |
| 09/30/1999 | WO1999042465A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 09/30/1999 | WO1999041411A3 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 09/30/1999 | WO1999040904A3 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia |
| 09/30/1999 | WO1999038518A3 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation |
| 09/30/1999 | WO1999037167A3 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| 09/30/1999 | WO1999029308A3 Method for combating obesity |
| 09/30/1999 | CA2325588A1 Imidazolone anorectic agents: i. acyclic derivatives |
| 09/30/1999 | CA2325587A1 Imidazolone anorectic agents: ii. phenyl derivatives |
| 09/30/1999 | CA2325472A1 Imidazolone anorectic agents: iii. heteroaryl derivatives |
| 09/30/1999 | CA2324999A1 Methods for decreasing .beta.-amyloid protein |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/29/1999 | EP0944721A1 Adipocyte-specific differentiation-related protein |
| 09/29/1999 | EP0944648A1 Glp-1 derivatives |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944626A1 Tropane derivatives and method for their synthesis |
| 09/29/1999 | EP0944611A1 Dimesylate salts of neuropeptide y ligands |
| 09/29/1999 | EP0944602A1 Apo b-secretion/mtp inhibitory amides |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944396A1 Compositions and methods for enhancing intestinal function |
| 09/29/1999 | CN1230222A PTX-sensitive G proteins, prodn. and use thereof |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/29/1999 | CN1230119A Methods for enhancing lean tissue mass and bone mineral content and compsns therefor |
| 09/29/1999 | CN1230114A Novel treatment of leptine resistance |
| 09/29/1999 | CN1230110A Cell adhesion inhibitors |
| 09/29/1999 | CN1229655A Medicinal decoction for treating diabets mellitus |
| 09/29/1999 | CN1045294C Method for prepn. of indole derivatives |
| 09/28/1999 | US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections |
| 09/28/1999 | US5959103 Naphthofluorene compounds, intermediates, compositions, and methods |
| 09/28/1999 | US5958969 Osteoporosis |
| 09/28/1999 | US5958954 2,2-dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958917 Benzofluorene compounds, intermediates, compositions, and methods |
| 09/28/1999 | US5958913 Administering saturated sterol fatty acid ester |
| 09/28/1999 | US5958908 Sodium alendronate preparation for local administration |
| 09/28/1999 | US5958885 Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood |
| 09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | US5958426 Sphingolipids and a process thereto |
| 09/28/1999 | US5958421 Cosmetic or pharmaceutical composition containing an andiroba extract |
| 09/28/1999 | US5958417 Herbal combinations |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | CA2187803C Methods of treating disease using sertoli cells and allografts or xenografts |
| 09/23/1999 | WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047549A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 09/23/1999 | WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 09/23/1999 | WO1999047524A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047517A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | WO1999047160A1 Stabilized aqueous peptide solutions |
| 09/23/1999 | WO1999047154A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | WO1999047148A1 Composition from ginkgo biloba leaves, preparation and uses |
| 09/23/1999 | WO1999047138A1 Statin-matrix metalloproteinase inhibitor combinations |
| 09/23/1999 | WO1999047128A1 Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 09/23/1999 | WO1999047125A1 Controlled release oral tablet having a unitary core |
| 09/23/1999 | WO1999047123A1 Pharmaceutical composition containing a statin and aspirin |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 09/23/1999 | CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | CA2323439A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | CA2309588A1 Statin-matrix metalloproteinase inhibitor combinations |
| 09/23/1999 | CA2289621A1 Piperazines as inhibitors of fructose-1,6-bisphosphatase (fbpase) |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942915A1 Pharmaceutical formulations |
| 09/22/1999 | EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents |
| 09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
| 09/22/1999 | EP0942741A1 Lectin compositions and uses thereof |